Literature DB >> 3626208

Local recurrence of breast cancer: treatment of nine patients with a recurrence in the skin flap of the chest wall.

T Naruse, A Koike, A Miyashita, K Matsumoto, K Suzumura, T Kanemitsu, K Kato, S Yamamoto.   

Abstract

From 1975 through 1985, nine patients with a local recurrent lesion (LRL) of breast cancer to the skin flap of the chest wall were treated. Four had undergone primary mastectomies in our clinic and the other five were referred from other surgeons, following signs of recurrence. Aggressive topical therapy, such as resection or irradiation, proved effective in eradicating the LRL in all cases, thereby indicating that topical therapy is useful for improving quality of life. Adjuvant systemic chemo-immuno-endocrine therapy is also required for patients with LRL, to increase longevity. Seven of the patients died of a distant metastasis within 66 months after the onset of LRL.

Entities:  

Mesh:

Year:  1987        PMID: 3626208     DOI: 10.1007/BF02470645

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  6 in total

1.  The nature of local recurrence following radical mastectomy.

Authors:  H AUCHINCLOSS
Journal:  Cancer       Date:  1958 May-Jun       Impact factor: 6.860

2.  Patterns of recurrent disease in breast cancer.

Authors:  J Bruce; D C Carter; J Fraser
Journal:  Lancet       Date:  1970-02-28       Impact factor: 79.321

3.  The implications of local recurrence of breast cancer as the first site of therapeutic failure.

Authors:  M D Gilliland; R M Barton; E M Copeland
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

4.  Steroid-hormone receptors and survival after first relapse in breast cancer.

Authors:  A Howell; D M Barnes; R N Harland; J Redford; V H Bramwell; M J Wilkinson; R Swindell; D Crowther; R A Sellwood
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

5.  Treatment of disseminated breast cancer with tamoxifen, aminoglutethimide, hydrocortisone, and danazol, used in combination or sequentially.

Authors:  T J Powles; S Ashley; H T Ford; J C Gazet; A G Nash; A M Neville; R C Coombes
Journal:  Lancet       Date:  1984-06-23       Impact factor: 79.321

6.  A randomized study of combination chemotherapy (VAC-FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancer.

Authors:  D Fritze; R Becher; B Massner; M Kaufmann; U Bruntsch; W M Gallmeier; A C Mayr; P Drings; U Abel; L Edler; W F Jungi; W Queisser; H J Senn
Journal:  Klin Wochenschr       Date:  1982-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.